Very well said.
Start up biotechs are risky. Anyone who was posting with such extreme confidence about trial outcomes and FDA approvals is either unaware of the risks or, more likely, has another agenda.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Update on COVID-19 ARDS Trial
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-304
-
-
- There are more pages in this discussion • 772 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.15 |
Change
-0.040(3.36%) |
Mkt cap ! $1.370B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $3.982M | 3.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 71292 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 21383 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 5601 | 1.155 |
14 | 95990 | 1.150 |
15 | 125434 | 1.145 |
13 | 226818 | 1.140 |
7 | 139822 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.160 | 39912 | 9 |
1.165 | 90797 | 10 |
1.170 | 95234 | 10 |
1.175 | 8065 | 3 |
1.180 | 45423 | 7 |
Last trade - 12.53pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |